Literature DB >> 15615658

Cancer in the elderly: pancreatic cancer.

Susannah Shore1, Dale Vimalachandran, Michael G T Raraty, Paula Ghaneh.   

Abstract

Pancreatic cancer remains a devastating and difficult disease to diagnose and successfully treat. Its incidence increases with age, with 60% of patients being over the age of 65 at presentation. Due to the insidious nature and asymptomatic onset of pancreatic cancer approximately 85% of patients present with disseminated or locally advanced disease resulting in a very poor prognosis. In the past the elderly patient, who may be felt to be too frail for operative procedures or further therapy, may have missed out on optimal treatment. In this article we review the investigation and treatment of pancreatic cancer and examine current evidence with regard to pancreatic cancer in the elderly. The evidence suggests that surgical resection can be performed safely in patients who are fit for surgery in specialist centres but may require more intensive post-operative rehabilitation.

Entities:  

Mesh:

Year:  2004        PMID: 15615658     DOI: 10.1016/j.suronc.2004.11.001

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  15 in total

1.  Surgical palliation of unresectable pancreatic head cancer in elderly patients.

Authors:  Sang Il Hwang; Hyung Ook Kim; Byung Ho Son; Chang Hak Yoo; Hungdai Kim; Jun Ho Shin
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

2.  Outcomes of resected pancreatic cancer in patients age ≥70.

Authors:  Thomas J Hayman; Tobin Strom; Gregory M Springett; Lodovico Balducci; Sarah E Hoffe; Kenneth L Meredith; Pamela Hodul; Mokenge Malafa; Ravi Shridhar
Journal:  J Gastrointest Oncol       Date:  2015-10

3.  Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice.

Authors:  Krishna Kattel; Goutam Mondal; Feng Lin; Virender Kumar; Ram I Mahato
Journal:  Mol Pharm       Date:  2016-11-07       Impact factor: 4.939

4.  Prognostic factors in periampullary and pancreatic tumor resection in elderly patients.

Authors:  R Casadei; N Zanini; A M Morselli-Labate; L Calculli; R Pezzilli; O Potì; T Grottola; C Ricci; F Minni
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

5.  Survival after pancreaticoduodenectomy for ampullary cancer is not affected by age.

Authors:  Chi-Chuan Yeh; Yung-Ming Jeng; Cheng-Maw Ho; Rey-Heng Hu; Hsiu-Pi Chang; Yu-Wen Tien
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

6.  Do not deny pancreatic resection to elderly patients.

Authors:  Roberto Ballarin; Mario Spaggiari; Fabrizio Di Benedetto; Roberto Montalti; Michele Masetti; Nicola De Ruvo; Antonio Romano; Gian Piero Guerrini; Maria Grazia De Blasiis; Giorgio Enrico Gerunda
Journal:  J Gastrointest Surg       Date:  2008-09-11       Impact factor: 3.452

Review 7.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.

Authors:  Chitta Ranjan Patra; Resham Bhattacharya; Debabrata Mukhopadhyay; Priyabrata Mukherjee
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

8.  Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer.

Authors:  Sahil Aggarwal; Swati Gupta; Dilrose Pabla; R S R Murthy
Journal:  Cancer Nanotechnol       Date:  2013-09-24

9.  Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.

Authors:  Rachel A Kudgus; Annamaria Szabolcs; Jameel Ahmad Khan; Chad A Walden; Joel M Reid; J David Robertson; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival.

Authors:  Faruk Tas; Fatma Sen; Serkan Keskin; Leyla Kilic; Ibrahim Yildiz
Journal:  Mol Clin Oncol       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.